2022
DOI: 10.1007/s11910-022-01175-w
|View full text |Cite
|
Sign up to set email alerts
|

Post-traumatic Headache: Pharmacologic Management and Targeting CGRP Signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 55 publications
0
4
0
Order By: Relevance
“…There seems to be an inverse relationship between the severity of head trauma and the occurrence of posttraumatic headaches. [ 28 , 29 ] Although the use of analgesics, such as ibuprofen, may be beneficial in the short-term, rebound headaches are common and can complicate treatment and recovery. [ 30 ] Therefore, their frequent use should be discouraged.…”
Section: Discussionmentioning
confidence: 99%
“…There seems to be an inverse relationship between the severity of head trauma and the occurrence of posttraumatic headaches. [ 28 , 29 ] Although the use of analgesics, such as ibuprofen, may be beneficial in the short-term, rebound headaches are common and can complicate treatment and recovery. [ 30 ] Therefore, their frequent use should be discouraged.…”
Section: Discussionmentioning
confidence: 99%
“…Western medicine can help improve headache symptoms to a certain extent. Simultaneously, the adverse effects of drugs and long-term medication can cause greater psychological stress in patients and serious disturbances in sleep quality [13–15] . Therefore, it is necessary to identify safe and effective treatments that have minimal adverse effects.…”
Section: Discussionmentioning
confidence: 99%
“…Another study found that an intravenous infusion of CGRP triggers migraine-like headaches in people with PPCS, highlighting the significant role of CGRP in the genesis of post-traumatic headaches [122]. These connections suggest that targeting neuroinflammation early after concussion injuries may disrupt the cascade of events, potentially preventing PPCS development [123].…”
Section: Decreasing Neuroinflammationmentioning
confidence: 99%